Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Note 13 - Capital and Other Components of Equity (Tables)

v3.8.0.1
Note 13 - Capital and Other Components of Equity (Tables)
12 Months Ended
Mar. 31, 2018
Statement Line Items [Line Items]  
Disclosure of convertible debentures [text block]
Accrued interest as at     Share issuance date       Number of shares       Amount
$
 
                         
March 31, 2017    
April 7, 2017
     
9,496
     
17
 
June 30, 2017    
August 15, 2017
     
23,885
     
40
 
September 30, 2017    
December 27, 2017
     
22,783
     
40
 
December 31, 2017    
March 27, 2018
     
33,605
     
40
 
     
 
     
89,769
     
137
 
Class of warrant or right outstanding [text block]
     
March 31, 2018
     
March 31, 2017
      February 28, 2017
(Unaudited)
      February 29, 2016  
     
Number
outstanding
      Amount      
Number
outstanding
      Amount      
Number outstanding
      Amount      
Number outstanding
      Amount  
             
$
             
$
             
$
             
$
 
Liability                                                                
Series December 2017                                                                
US public offering Warrants 2017 (i)    
9,802,935
     
6,405
     
     
     
     
     
     
 
Series 8 Public offering                                                                
Warrants December 2013 (note 11) (ii)    
18,400,000
     
21
     
18,400,000
     
209
     
18,400,000
     
187
     
18,400,000
     
156
 
     
28,202,935
     
6,426
     
18,400,000
     
209
     
18,400,000
     
187
     
18,400,000
     
156
 
Equity                                                                
Public offering warrants                                                                
Series December 2017 US Broker warrants (v)    
495,050
     
406
     
     
     
     
     
     
 
Series 2017 BW Broker warrants (iii)    
     
     
234,992
     
144
     
234,992
     
144
     
     
 
Public offering warrants February 2017 (iv)    
1,904,034
     
     
1,965,259
     
     
1,965,259
     
     
     
 
Private Placement – contingent warrants                                                                
2017 Unsecured convertible debenture conversion option and contingent warrants (vi)    
1,052,630
     
309
     
1,052,630
     
309
     
1,052,630
     
309
     
     
 
Series 9 Private Placement warrants 2013 (vii)    
161,654
     
     
161,654
     
     
161,654
     
     
161,654
     
 
     
3,613,368
     
715
     
3,414,535
     
453
     
3,414,535
     
453
     
161,654
     
 
Warrants [member]  
Statement Line Items [Line Items]  
Disclosure of sensitivity analysis for actuarial assumptions [text block]
      December 27,
2017
 
Exercise price    
US $1.26
 
Share price    
US $0.97
 
Risk-free interest    
2.22
%
Estimated life (in years)    
5
 
Expected volatility    
93.52
%
      December 27,
2017
 
Exercise price    
US $1.2625
 
Share price    
US $0.97
 
Risk-free interest    
2.22
%
Estimated life (in years)    
5
 
Expected volatility    
93.52
%
     
February 21, 2017
 
         
Exercise price  
$2.15
 
Share price  
$1.70
 
Dividend    
 
Risk-free interest    
0.79
%
Estimated life (in years)    
1.00
 
Expected volatility    
112.09
%